logo-loader

Albireo Pharma Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$238.76 m
Price
18.82 USD
Change
0.97%
52 weeks high
38.48
52 weeks low
16.26

In brief

Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders.  We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Our parent company, Albireo Pharma, Inc., is located in Boston, Massachusetts and our key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden. We were spun out from AstraZeneca in 2008.